“Research and innovation are increasingly global, for the simple reason that they must offer solutions to global challenges without national borders, including the COVID-19 pandemic. Since the onset of the COVID-19 pandemic, the EU has supported research partnerships between EU and countries around the globe, including with researchers in ASEAN. So far, the EU has invested EUR 780 million into research and innovation programmes targeting the pandemic,” said Ambassador Piket.
The EU is also a strong supporter of the COVAX Facility, the global initiative that engages 90% of the world’s population and aims to ensure fair and equitable access to COVID-19 vaccines for all.
“Through Team Europe, the EU and its Member States are providing 40% of the funding of the COVAX Facility with EUR 2.2 billion. This funding will bring us closer to achieving COVAX’s target to deliver 2 billion doses of vaccines to 92 low- and middle-income countries by the end of 2021, including Indonesia. In the first batch of the vaccines, which will be distributed by the COVAX Facility in Q1 and Q2 of 2021, Indonesia is expected to receive more than 13 million vaccines from COVAX,” added Ambassador Piket.
Leave a Reply